AHA Coding Clinic® for HCPCS - 2018 Issue 2; For Your Information

New HCPCS codes for drugs and biologicals with OPPS pass-through status

Here is a listing of several HCPCS codes, long descriptor, and effective dates, granted OPPS pass-through status listed in the table below. HCPCS Code Long Descriptor Pass-through Status Effective Date C9462 Injection, delafloxacin, 1 mg April 1, 2018 C9463 Injection, aprepitant, 1 mg April 1, 2018 C9464 Injection, rolapitant, 0.5 mg April 1, 2018 C9465 Hyaluronan or derivative, Durolane, for intra-articular injection, per dose April 1, 2018 C9466 Injection, benralizumab, 1 mg April 1, 2018 C9467 Injection, rituximab and hyaluronidase, 10 mg April 1, 2018 C9468 Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, Rebinyn, 1 i.u. April...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.